Skip to main content

Day: August 17, 2020

Philips introduces OmniWire, the world’s first solid core pressure guide wire for coronary artery interventional procedures

August 17, 2020 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the introduction of OmniWire, the world’s first solid core pressure wire for coronary artery interventional procedures. With its breakthrough solid core construction, physicians can more easily maneuver the wire in the patient’s circulatory system to measure blood pressure along the vessel and guide the delivery of catheters and stents. The new wire supports iFR (instant wave-Free Ratio) measurements, the only resting index supported by randomized controlled outcome trials [1-3], as well as FFR (fractional flow reserve) measurements. It also integrates with the Philips IntraSight interventional applications platform, which can co-register iFR data onto the angiogram (interventional X-ray image) to precisely...

Continue reading

First Federal Community Foundation Receives Corporate Citizenship Award from Puget Sound Business Journal

PORT ANGELES, Wash., Aug. 17, 2020 (GLOBE NEWSWIRE) — First Northwest Bancorp (NASDAQ: FNWB) (“Company”), the holding company for First Federal Savings and Loan Association of Port Angeles (“Bank” or “First Federal”), and First Federal Community Foundation, were recently recognized by the Puget Sound Business Journal as one of the top corporate philanthropists in Washington State. Of the 26 midsize companies that made the Journal’s list, First Federal Bank and Foundation collectively contributed $1.06 million, and ranked #2.  Together, these 26 midsized companies contributed $10.6 million to Washington nonprofits.The combined contributions of the Bank and its Foundation to Washington non-profit organizations was acknowledged at the annual Corporate Citizenship Awards hosted virtually by the Puget Sound Business Journal on August...

Continue reading

Noodles & Company Announces CFO Departure

BROOMFIELD, Colo., Aug. 17, 2020 (GLOBE NEWSWIRE) — Noodles & Company (NASDAQ:NDLS), today announced the resignation of Chief Financial Officer, Ken Kuick, to pursue other business interests effective August 21, 2020.Dave Boennighausen, Chief Executive Officer of Noodles & Company, said, “On behalf of our entire team, I would like to thank Ken for his commitment and contribution to Noodles & Company. Since joining Noodles in 2018, Ken has been a valuable member of our management team and we wish him well in his future endeavors.”“It has been a great pleasure to serve as CFO of Noodles & Company over the past two years,” said Ken Kuick. “I have the utmost confidence in the brand, and I am grateful for the opportunity to work with one of the most dedicated teams in the restaurant industry.”The Company has commenced...

Continue reading

Comstock Holding Companies Reports Second Quarter 2020 Results

WASHINGTON and RESTON, Va., Aug. 17, 2020 (GLOBE NEWSWIRE) — On August 14, 2020, Comstock Holding Companies, Inc., (NASDAQ: CHCI) (the “Company”), announced results for the three and six months ended June 30, 2020:Highlights of Second Quarter 2020, as compared to Second Quarter 2019:Net income increased to $1.2 million during the second quarter 2020, as compared to a net loss of $0.2 million during the same period of the prior year.Total revenue increased by 21% to $6.5 million during the second quarter 2020, as compared to $5.3 million during the same period of the prior year.Revenue from asset management operations decreased by 7% to $4.1 million during the second quarter 2020, as compared to $4.4 million during the same period of the prior year, due to cost reductions resulting from receipt of financing proceeds received under...

Continue reading

C-Bond Systems Provides Second Quarter 2020 Operational Update

HOUSTON, Aug. 17, 2020 (GLOBE NEWSWIRE) — C-Bond Systems, Inc. (the “Company” or “C-Bond”) (OTC: CBNT), a nanotechnology solutions company, has reported an operational update and financial results for the second quarter ended June 30, 2020.Second Quarter 2020 and Subsequent Operational HighlightsSigned C-Bond NanoShield private label supply agreement with a premier provider of vehicle protection solutions to thousands of automotive dealerships nationwide.Entered into an exclusive supply agreement with a large overseas conglomerate to sell a version of C-Bond NanoShield™ with annual minimum purchase requirements in excess of $1 million to maintain exclusivity.Announced an exclusive, nationwide distribution agreement with Quip Laboratories, Inc. for MB-10 Tablets, an EPA-registered disinfectant to help in the fight against COVID-19.The...

Continue reading

Resonant Appoints Global Technology Industry Leader Glen Riley to Advisory Board

GOLETA, Calif., Aug. 17, 2020 (GLOBE NEWSWIRE) — Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for mobile handset and wireless devices, today announced the appointment of Glen Riley, a global technology industry leader, to its Advisory Board.Mr. Riley joins Resonant’s Advisory Board with over 32 years of successful executive-level experience in the RF, foundry, optical and storage industries. Most recently, Mr. Riley held the role of General Manager of the Filter Solutions Business Unit at Qorvo, where he was responsible for developing discrete and integrated module BAW and SAW devices for mobile phones.In his role with Resonant, Mr. Riley will bring extensive business guidance and technology expertise to help accelerate growth as the Company continues...

Continue reading

BioSyent Schedules Q2 and H1 2020 Earnings Release for August 26, 2020

MISSISSAUGA, Ontario, Aug. 17, 2020 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and six months ended June 30, 2020 on Wednesday, August 26, 2020.  A presentation on the Company’s second quarter and first half 2020 results by René Goehrum, BioSyent President and CEO, will also be available on the Company’s website on the date of release.About BioSyent Inc.Listed on the TSX Venture Exchange under the trading symbol “RX”, BioSyent is a profitable growth-oriented specialty pharmaceutical company focused on in-licensing or acquiring innovative pharmaceutical and other healthcare products that have been successfully developed, are safe and effective, and have a proven track record of improving the lives of patients.  BioSyent supports the healthcare...

Continue reading

AgEagle Aerial Systems Reports Second Quarter 2020 Results

NEODESHA, Kan., Aug. 17, 2020 (GLOBE NEWSWIRE) — AgEagle Aerial Systems Inc. (NYSE American: UAVS) (“AgEagle or the “Company”), an industry leading provider of UAVs and advanced aerial imagery, data collection and analytics solutions, today announced its second quarter financial results for the three and six months ended June 30, 2020.Key Financial HighlightsRevenue increased 516% to $408,000 from $66,000 for the six-month comparable periods in 2020 and 2019. For the three months ended June 30, 2020, revenue was $16,000 compared to $20,000 for the same three months in the prior year. This decline was primarily due to the impact of COVID-19 on AgEagle’s supply chain, resulting in the delivery delay of certain parts needed for the manufacturing and assembly of drones and related drone package delivery equipment. Approximately $770,000...

Continue reading

Yield10 Bioscience Obtains Positive Response from USDA-APHIS on Regulated Status of its CRISPR Genome-Edited C3007 Trait in Canola; Plans U.S. Field Tests for 2021

WOBURN, Mass., Aug. 17, 2020 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that it has obtained a positive response from USDA-APHIS’s Biotechnology Regulatory Services (BRS) for its CRISPR genome-edited trait C3007 in canola plant lines developed for increased oil content.  Yield10’s submission along with the USDA-APHIS BRS response is posted on the USDA’s website.  In June 2020, Yield10 submitted an “Am I regulated?” letter to the BRS, requesting confirmation of the regulatory status for canola plant lines containing the Company’s novel, CRISPR genome-edited C3007 trait. The positive USDA-APHIS response came in the form of a published letter indicating that the plant lines do not meet the definition of a regulated article under 7 CFR Part 340 regulations. Confirmation...

Continue reading

Entera Bio to Report Second Quarter 2020 Business and Financial Results on August 20, 2020

BOSTON and JERUSALEM, Aug. 17, 2020 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, announced it will report business and financial results for the quarter ended June 30, 2020 on August 20, 2020, before the U.S. financial markets open. Entera’s management will host a conference call on Thursday, August 20, 2020 at 8:30 a.m. EDT to discuss the results for the quarter. A question-and-answer session will follow Entera’s remarks. To participate on the live call, please dial (855) 547-3865 (US) or (409) 217-8787 (international) and provide the conference ID “5243229” five to ten minutes before the start of the call.To access a live audio webcast of the presentation on the “Investor Relations” page of Entera’s website, please click here. A replay of the webcast...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.